Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake

Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake

Neuroendocrine differentiation (NED) of prostate cancer represents an acknowledged predictor of resistant and more aggressive disease. NED can be functionally exploited in vivo using PET/CT imaging with somatostatin analogs radiolabeled with 68Ga. Many previous reports have shown that 18F-FDG PET/CT...

Full description

Bibliographic Details
Main Authors: Matteo Bauckneht, Silvia Morbelli, Alberto Miceli, Sara Elena Rebuzzi, Giuseppe Fornarini
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Diagnostics
Subjects:
metastatic castration-resistant prostate cancer
neuroendocrine differentiation
positron emission tomography
18F-Fluorodeoxyglucose
68Ga-Dotatoc
Online Access:https://www.mdpi.com/2075-4418/11/3/468

Internet

https://www.mdpi.com/2075-4418/11/3/468

Similar Items